Related Experiment Video
Updated: Jun 7, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x
Lulzim Shkreta1, Laetitia Michelle, Johanne Toutant
1RNA/RNP Group, Département de Microbiologie et d'Infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
Abstract:
Alternative splicing often produces effectors with opposite functions in apoptosis. Splicing decisions must therefore be tightly connected to stresses, stimuli, and pathways that control cell survival and cell growth. We have shown previously that PKC signaling prevents the production of proapoptotic Bcl-x(S) to favor the accumulation of the larger antiapoptotic Bcl-x(L) splice variant in 293 cells. Here we show that the genotoxic stress induced by oxaliplatin elicits an ATM-, CHK2-, and p53-dependent splicing switch that favors the production of the proapoptotic Bcl-x(S) variant. This DNA damage-induced splicing shift requires the activity of protein-tyrosine phosphatases. Interestingly, the ATM/CHK2/p53/tyrosine phosphatases pathway activated by oxaliplatin regulates Bcl-x splicing through the same regulatory sequence element (SB1) that receives signals from the PKC pathway. Convergence of the PKC and DNA damage signaling routes may control the abundance of a key splicing repressor because SB1-mediated repression is lost when protein synthesis is impaired but is rescued by blocking proteasome-mediated protein degradation. The SB1 splicing regulatory module therefore receives antagonistic signals from the PKC and the p53-dependent DNA damage response pathways to control the balance of pro- and antiapoptotic Bcl-x splice variants.
Insights
Genotoxic stress triggers a DNA damage response, shifting Bcl-x splicing towards the pro-apoptotic variant. This switch, regulated by ATM/CHK2/p53 and tyrosine phosphatases, balances cell survival and death signals.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Alternative splicing generates protein isoforms with opposing functions, crucial for regulating apoptosis.
- Protein kinase C (PKC) signaling influences Bcl-x splicing, favoring the anti-apoptotic Bcl-x(L) variant.
Purpose of the Study:
- To investigate the role of DNA damage response pathways in regulating alternative splicing of Bcl-x.
- To elucidate the molecular mechanisms by which genotoxic stress influences the balance of pro- and anti-apoptotic Bcl-x splice variants.
Main Methods:
- Utilized oxaliplatin to induce genotoxic stress in cell models.
- Investigated the involvement of ATM, CHK2, p53, and protein-tyrosine phosphatases in splicing regulation.
- Analyzed the role of the SB1 regulatory sequence element in mediating splicing control.
- Assessed the impact of impaired protein synthesis and proteasome inhibition on splicing.
Main Results:
- Genotoxic stress induced by oxaliplatin activates an ATM-, CHK2-, and p53-dependent switch favoring pro-apoptotic Bcl-x(S) production.
- This DNA damage-induced splicing shift requires protein-tyrosine phosphatase activity.
- The ATM/CHK2/p53/tyrosine phosphatases pathway converges with the PKC pathway at the SB1 regulatory element.
- SB1-mediated repression is dependent on protein synthesis and proteasomal degradation.
Conclusions:
- The DNA damage response pathway antagonistically regulates Bcl-x splicing compared to PKC signaling.
- The SB1 splicing regulatory module integrates signals from both pathways to control the Bcl-x splice variant balance.
- This mechanism is critical for determining cell fate decisions between survival and apoptosis under genotoxic stress.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
RNA Splicing
Apoptosis

